The long tail of oncogenic drivers in prostate cancer

Journal: Nature Genetics

Published: 2018-04-02

DOI: 10.1038/s41588-018-0078-z

Affiliations: 20

Authors: 39

Go to article
Institutions FC
Human Oncology and Pathogenesis Program (HOPP), MSKCC, United States of America (USA) 0.15
Marie-Josée and Henry R. Kravis Center for Molecular Oncology, MSKCC, United States of America (USA) 0.12
Michigan Center for Translational Pathology (MCTP), U-M, United States of America (USA) 0.10
Department of Medical Oncology, DFCI, United States of America (USA) 0.10
Cancer Area, Broad Institute, United States of America (USA) 0.10
Department of Medicine, MSKCC, United States of America (USA) 0.08
Department of Pathology and Laboratory Medicine, Cornell University, United States of America (USA) 0.06
Clinical Research Division, FHCRC, United States of America (USA) 0.04
Department of Medicine, UW, United States of America (USA) 0.04
The Royal Marsden Hospital - London, The Royal Marsden NHS Foundation Trust, United Kingdom (UK) 0.03
Department of Laboratory Medicine, UW, United States of America (USA) 0.03
Department of Urology, UW, United States of America (USA) 0.03
Centre for Integrative Biology (CIBIO), UNITN, Italy 0.03
ICR Clinical Trials and Statistics Unit (ICR-CTSU), United Kingdom (UK) 0.03
ICR Division of Clinical Studies, United Kingdom (UK) 0.03
Department of Epidemiology and Biostatistics, MSKCC, United States of America (USA) 0.02
Sandra and Edward Meyer Cancer Center, Cornell University, United States of America (USA) 0.02
Weill Cornell Medicine (WCM), Cornell University, United States of America (USA) 0.02
Division of Hematology and Medical Oncology, Cornell University, United States of America (USA) 0.01
Human Biology Division, FHCRC, United States of America (USA) 0

Return